Lung Institute’s Medical Director Celebrates 55th Anniversary in Medical Practice

Share Article

Dr. Burton Feinerman Still Influencing Medical Change as Stem Cell Pioneer

This month marks a milestone for the Lung Institute’s Medical Director, Dr. Burton Feinerman, as he celebrates his 55th anniversary in the medical field. Practicing medicine for over half a century, Dr. Feinerman has distinguished himself as a world-renowned physician in the field of regenerative medicine with the development of innovative stem cell treatments for lung diseases like chronic obstructive pulmonary disease (COPD).

Dr. Feinerman’s medical career has been punctuated by many firsts. In the 1950s and 1960s, Dr. Feinerman was the owner of Opa-Locka General Hospital, the only private hospital accepting African Americans in Miami, Florida. He also set up the first Pediatric Emergency Rooms in South Florida at Parkway Hospital and Miami General Hospital.

The Lung Institute’s medical director was also involved with the first successful allogeneic (genetically dissimilar) bone marrow transplant performed on a 10-month-old child with severe combined/immunodeficiency, known as “bubble baby.” This patient, who was given a very poor prognosis of life expectancy, is now 36-years-old and a high school teacher. In 1998, Dr. Feinerman set up the first medical service website site,, to directly answer patient questions, which later became a public company.

It was during his time in Hawaii as the first physician to offer cosmetic dermatology and anti-aging medicine that Dr. Feinerman initially became interested in stem cells. Over subsequent years, he developed stem cell patents for a variety of disorders including Amyotrophic Lateral Sclerosis (ALS), Parkinson’s, Alzheimer’s, multiple sclerosis, autism, cerebral palsy, COPD, pulmonary fibrosis, diabetes types 1 and 2, end-stage kidney disease and brain damage in children and adults. He also developed patents for gene therapies to treat such conditions as Tay-Sachs, Sandhoff disease, Huntington’s disease and metachromatic leukodystrophy.

Dr. Feinerman’s stem cell quest continues at Regenerative Medicine Solutions and Lung Institute, with his current research aimed at conquering neurological and chronic lung diseases as well as diseases causing blindness such as age-related macular degeneration, retinitis pigmentosa, and stargardt’s disease.

“I am humbled at the acknowledgement of my role as a catalyst for change in medicine,” confessed Dr. Feinerman who was honored last year as Lifetime Achievement Award finalist for the Tampa Bay Business Journal’s Healthcare Heroes. “When I reflect back on my medical career, I only see my patients.”

About the Lung Institute
At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at, like us on Facebook, follow us on Twitter or call us today at (855) 469-5864.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Phoebe Ochman
Visit website